QuantRx Biomedical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of QuantRx Biomedical generated cash of $0, which is more than the previous year. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2013 | -149.53K | 80K | 64K |
|---|---|---|---|
| 2014 | -291.91K | 120K | 386K |
| 2015 | -226.37K | -50K | 118.91K |
| 2016 | -94.64K | 0 | 34.25K |
| 2017 | -150.61K | 496.94K | 113.08K |
| 2018 | -257.92K | 200.58K | -80.75K |
| 2019 | -191.67K | 0 | 0 |
| 2020 | -74.92K | 0 | 0 |
| 2021 | -49.47K | 0 | 0 |
| 2022 | 0 | 0 | 0 |
QTXB Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.95K | 55.42K | 130.35K | 322.02K | 460.11K | 691 | 61.07K | 218.54K | 4.45K | 9.98K |
Operating activities | ||||||||||
Net income | 0 | -260.04K | -252.73K | -621.92K | -736.85K | 869.13K | -397.99K | -467.78K | -826.98K | -358.33K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 0 | 10.85K | 7.17K | 9.66K | 9.66K | 9.18K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55K | 21 | 39K |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55K | 21 | 39K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 352 | 565 | 1.41K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.58M | 1.97K | 586 |
Accounts payable | 0 | -6.09K | -21.3K | 6.61K | -12.02K | 19.72K | 38.85K | -57.48K | 176.89K | 118.52K |
Cash generated by operating activities | 0 | -49.47K | -74.92K | -191.67K | -257.92K | -150.61K | -94.64K | -226.37K | -291.91K | -149.53K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | 200.58K | 496.94K | 0 | -50K | 120K | 80K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 68.70K | 25K | 63.76K | 9K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | -20K | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | -60.75K | 113.08K | -1.74K | -2.59K | 0 | 0 |
Cash used in financing activities | 0 | 0 | 0 | 0 | -80.75K | 113.08K | 34.25K | 118.91K | 386K | 64K |
Net Change In Cash | 0 | -49.47K | -74.92K | -191.67K | -138.08K | 459.42K | -60.38K | -157.46K | 214.08K | -5.53K |
Cash at end of period | 5.95K | 5.95K | 55.42K | 130.35K | 322.02K | 460.11K | 691 | 61.07K | 218.54K | 4.45K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |